BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32771472)

  • 1. Differential SATB1 Expression Reveals Heterogeneity of Cutaneous T-Cell Lymphoma.
    Gao Y; Liu F; Sun J; Wen Y; Tu P; Kadin ME; Wang Y
    J Invest Dermatol; 2021 Mar; 141(3):607-618.e6. PubMed ID: 32771472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB1 in Malignant T Cells.
    Fredholm S; Willerslev-Olsen A; Met Ö; Kubat L; Gluud M; Mathiasen SL; Friese C; Blümel E; Petersen DL; Hu T; Nastasi C; Lindahl LM; Buus TB; Krejsgaard T; Wasik MA; Kopp KL; Koralov SB; Persson JL; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Becker JC; Ødum N
    J Invest Dermatol; 2018 Aug; 138(8):1805-1815. PubMed ID: 29751003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
    Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB1 Defines a Subtype of Cutaneous CD30
    Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
    J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21.
    Wang Y; Gu X; Zhang G; Wang L; Wang T; Zhao Y; Zhang X; Zhou Y; Kadin M; Tu P
    Blood; 2014 May; 123(22):3452-61. PubMed ID: 24747435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
    de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformed mycosis fungoides: clinicopathological features and outcome.
    Barberio E; Thomas L; Skowron F; Balme B; Dalle S
    Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.
    Vergier B; de Muret A; Beylot-Barry M; Vaillant L; Ekouevi D; Chene G; Carlotti A; Franck N; Dechelotte P; Souteyrand P; Courville P; Joly P; Delaunay M; Bagot M; Grange F; Fraitag S; Bosq J; Petrella T; Durlach A; De Mascarel A; Merlio JP; Wechsler J
    Blood; 2000 Apr; 95(7):2212-8. PubMed ID: 10733487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
    Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
    Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of SATB1 expression with clinical course of cutaneous T-cell lymphomas.
    Grzanka A; Grzanka D; Gagat M; Tadrowski T; Sokołowska-Wojdyło M; Marszałek A; Placek W
    Pol J Pathol; 2012 Jun; 63(2):101-5. PubMed ID: 22864778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis.
    Alberti-Violetti S; Sapienza MR; Del Corvo M; Melle F; Motta G; Venegoni L; Cerroni L; Cota C; Pileri A; Berti E; Pileri SA
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
    Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK
    Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression.
    Wang RC; Sakata S; Chen BJ; Chang ST; Hsieh PP; Yang CS; Baba S; Takeuchi K; Chuang SS
    Pathology; 2018 Dec; 50(7):718-724. PubMed ID: 30348505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma.
    Yamaguchi T; Ohshima K; Tsuchiya T; Suehuji H; Karube K; Nakayama J; Suzumiya J; Yoshino T; Kikuchi M
    Eur J Dermatol; 2003; 13(6):553-9. PubMed ID: 14721775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
    Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
    Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.
    Quaglino P; Fava P; Pileri A; Grandi V; Sanlorenzo M; Panasiti V; Guglielmo A; Alberti-Violetti S; Novelli M; Astrua C; Rubatto M; Tonella L; Berti E; Pimpinelli N; Osella Abate S; Fierro MT; Vermeer M; Scarisbrick JJ; Ribero S
    J Invest Dermatol; 2021 Mar; 141(3):484-495. PubMed ID: 33162051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.